The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
Low Confidence Animal StudyPrimary source: [Open]
Linked compounds: mots-c
Outcomes summary
Preclinical study reporting metabolic effects of MOTS-c in models of obesity and insulin resistance, with mechanistic experiments in model systems.
Limitations
Preclinical; does not establish human efficacy or long-term safety.
Notes
Primary source: PMID 25738459.